Cancer can affect anyone, but it doesn’t strike randomly. Roughly 1 in 3 people will develop invasive cancer in their lifetime, and certain factors dramatically shift those odds. Age is the single biggest predictor: the median age at diagnosis is 67, and more than 80% of new cases occur in people over 45. Beyond age, your risk depends on a mix of genetics, lifestyle, environmental exposures, infections, and socioeconomic circumstances.
Age Is the Strongest Risk Factor
Cancer is overwhelmingly a disease of middle and older age. Less than 1% of new cases occur in people under 20, and only about 3% affect those between 20 and 34. The numbers climb steeply after 45: people aged 55 to 74 account for more than half of all new diagnoses. The 65-to-74 age group alone makes up nearly a third of cases.
This pattern exists because cancer develops from accumulated DNA damage over time. Every year of life adds more cell divisions, more exposure to carcinogens, and more chances for the repair systems in your cells to miss a mistake. That’s why pediatric cancers are biologically different from adult cancers. They tend to arise from developmental errors rather than decades of wear and tear.
Men and Women Face Nearly Equal Odds
The lifetime probability of developing invasive cancer is 39.9% for men and 39.0% for women, based on 2018 to 2021 data. That’s essentially equivalent overall, though the types of cancer differ significantly between the sexes. Prostate cancer is the most common diagnosis in men, while breast cancer leads in women. Lung and colorectal cancers rank high for both groups.
Most Cancer Is Not Inherited
Only 5% to 10% of all cancers are hereditary, meaning they result from a gene mutation present from birth. The remaining 75% to 80% are sporadic, caused by mutations that accumulate over a person’s lifetime in specific cells rather than being passed down from a parent. These acquired mutations are influenced by environmental exposures, lifestyle habits, infections, and sometimes just bad luck during normal cell division.
That said, the hereditary fraction matters enormously for the families it affects. Inherited mutations in genes like BRCA1 and BRCA2 can raise the risk of breast and ovarian cancer dramatically. If multiple close relatives developed cancer at young ages or developed the same type of cancer, genetic counseling can help determine whether a hereditary syndrome is involved. For most people, though, family history raises risk modestly rather than deterministically.
Tobacco, Diet, and Body Weight Drive the Most Cases
Lifestyle and environmental factors account for the vast majority of cancer deaths. Tobacco alone causes 25% to 30% of all cancer-related deaths and is responsible for 87% of lung cancer deaths. Diet contributes to an estimated 30% to 35% of cancer mortality through mechanisms that include chronic inflammation, exposure to processed food compounds, and nutrient deficiencies that impair DNA repair.
Excess body weight is another major driver. Being overweight or obese is linked to a higher risk of 13 types of cancer, which together make up 40% of all cancers diagnosed in the United States each year. These include cancers of the colon and rectum, breast (in postmenopausal women), kidneys, liver, pancreas, thyroid, uterus, ovaries, gallbladder, upper stomach, esophagus, a type of brain cancer called meningioma, and multiple myeloma. An estimated 14% of cancer deaths in men and 20% in women are attributable to excess weight.
Alcohol also contributes meaningfully. In cancers of the mouth, throat, and esophagus, 25% to 68% of cases are attributable to alcohol. Up to 80% of those tumors could be prevented by avoiding both alcohol and tobacco. Globally, about 3.5% of cancer deaths are linked to drinking.
Infections Cause About 13% of Cancers
Around 13% of cancers worldwide are directly caused by infectious agents. For certain cancer types, infections are responsible for nearly all cases. Cervical cancer is almost entirely driven by human papillomavirus (HPV). Non-cardia stomach cancer is strongly linked to H. pylori, a common bacterial infection. Hepatitis B and C viruses cause the majority of liver cancers globally.
This is one of the more actionable areas of cancer prevention. Vaccines for HPV and hepatitis B have already lowered cancer rates in younger generations. Antibiotics can eliminate H. pylori, and antiviral treatments can suppress hepatitis. In regions with high infection rates, these interventions represent some of the most effective cancer prevention tools available.
Workplace and Environmental Exposures
Certain occupations carry significantly elevated cancer risks. Researchers have identified 28 definite occupational carcinogens, 27 probable ones, and 113 possible ones. The best-known is asbestos, which causes lung cancer and mesothelioma in people who work in mining, insulation, shipyards, and asbestos cement production. Benzene, used widely in chemical manufacturing, the rubber industry, and gasoline production, causes leukemia. Hexavalent chromium compounds, encountered in plating, welding, leather tanning, and pigment production, cause lung and sinus cancers.
Other high-risk occupations include coke production, coal gasification, painting, boot and shoe manufacturing, and rubber production. Workers in these industries face elevated rates of bladder, lung, skin, and blood cancers. Coal tars and pitches, vinyl chloride, arsenic compounds, and certain nickel compounds are among the other confirmed carcinogens tied to specific workplaces. Regulations have reduced many of these exposures over the past several decades, but legacy exposures continue to cause diagnoses today because cancer often takes 20 to 40 years to develop after initial contact with a carcinogen.
Income and Race Shape Cancer Outcomes
Socioeconomic status is one of the strongest predictors of both cancer risk and survival. Research has found that income and education, more than race or ethnicity, predict access to health insurance, safe living conditions, and environments with lower exposure to toxins. People from low-income backgrounds bear a disproportionate burden of cancer.
Part of this disparity comes down to screening. Lower-income populations are less likely to follow recommended screening schedules and are more likely to be diagnosed at later stages, when treatment is less effective and survival rates drop significantly. Access to healthy food, safe places to exercise, and environments free from industrial pollution all correlate with income, creating a cascade of risk factors that cluster in underserved communities.
Racial and ethnic disparities also exist, though untangling them from socioeconomic factors is complex. Much of the difference in cancer outcomes between racial groups narrows or disappears when researchers control for income, insurance status, and access to care.
When Screening Starts
Because risk rises sharply with age, routine cancer screening is designed to catch common cancers before symptoms appear in the populations most likely to develop them. Colorectal cancer screening is now recommended starting at age 45 for people at average risk, meaning no prior polyps, no inflammatory bowel disease, and no family history of hereditary cancer syndromes like Lynch syndrome. Screening continues through age 75 as a strong recommendation and is selectively offered from 76 to 85 based on individual health and screening history.
People with higher-than-average risk due to family history, genetic syndromes, or certain medical conditions typically begin screening earlier and may need more frequent testing. Your personal combination of age, family history, lifestyle factors, and prior medical conditions determines when and how often screening makes sense for you.